PGNX - Progenics Pharmaceuticals EPS misses by $0.04 beats on revenue August, 09 2019 07:32 AM Progenics Pharmaceuticals Inc. Progenics Pharmaceuticals (NASDAQ:PGNX): Q2 GAAP EPS of -$0.23 misses by $0.04.More news on: Progenics Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...